Brian Gormley

Startups have developed AI software that executes tasks in areas such as clinical trials and appointment scheduling.

Healthcare entrepreneurs hope Robert F. Kennedy Jr. will streamline federal regulatory and funding mechanisms as secretary of the Department of Health and Human Services and push the U.S. medical system more toward prevention.

Justpoint has raised $95 million in new funding to search for drugs that cause harm and could be the basis for lawsuits.

C the Signs is using AI to sharpen predictions on cancer risk.

Biotechnology venture capital is recovering from its slide and investors are expressing optimism about 2025, even as they confront uncertainties weighing on their industry.

Biotechnology companies are developing novel obesity medicines to compete with blockbuster weight-loss drugs.

Venture capitalists are seeking startups with proprietary data, teams well-versed in both healthcare and technology.

Life sciences venture capitalists are fundraising at their slowest pace since before the pandemic, even though limited partner interest in the biomedical sector remains strong.

Healthcare investor says it has helped founders start more than 60 businesses since 2018.

Dimension has raised $500 million for its second venture fund targeting startups at the intersection of technology and life sciences as researchers increasingly apply tools such as artificial intelligence to biomedical research.